Brief: Biocartis Launches Liquid Biopsy Idylla ctEGFR Mutation Assay
Oct 25 (Reuters) - Biocartis Group NV BCART.BR :
* REG-PRESS RELEASE BIOCARTIS NV.: BIOCARTIS LAUNCHES LIQUID
BIOPSY IDYLLA™ CTEGFR MUTATION ASSAY
Source text for Eikon: ID:nGNE5jP9mY
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies